New Information on Drug Resistance: Implications for the Adjuvant Treatment of Breast Cancer
- 1 January 1989
- book chapter
- Published by Springer Nature
- Vol. 115, 8-16
- https://doi.org/10.1007/978-3-642-83337-3_2
Abstract
Extensive studies carried out over the past decade have abundantly confirmed the supposition that human cancer cells, both in vitro and in vivo, have an enormous capacity to develop variant phenotypes which display altered degrees of drug sensitivity. (Goldie and Coldman 1984; Von Hoff 1985). Evidence is accumulating that many of the mechanisms of specific drug resistance that have been identified in experimental systems are also likely to occur in clinical situations (Fojo et al. 1987).Keywords
This publication has 9 references indexed in Scilit:
- Prognostic factors for recurrence and survival in human breast cancerBreast Cancer Research and Treatment, 1987
- Comparison of Different Trials of Adjuvant Chemotherapy in Stage II Breast Cancer Using a Natural History Data BaseAmerican Journal of Clinical Oncology, 1987
- Molecular biology of drug resistanceBreast Cancer Research and Treatment, 1987
- Adjuvant systemic therapy for resectable breast cancer.Journal of Clinical Oncology, 1985
- Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP updateCancer, 1983
- A model for the resistance of tumor cells to cancer chemotherapeutic agentsMathematical Biosciences, 1983